INTRODUCTION
The presence of meconium-stained amniotic fluid (MSAF) is a potentially serious sign of fetal compromise associated with an increase in perinatal morbidity. 1, 2 Its presence is an indication for continuous fetal heart rate monitoring for reassurance of fetal well being. 3 Considerable controversy exists regarding the cause of passage of meconium in utero by the fetus. In utero hypoxia leading to relaxation of the anal sphincter has been considered the cause by many. Adverse intrauterine environment compromising fetal well being can lead to MSAF. Such an adverse intrauterine environment could be due to infection as evidenced by chorioamnionitis. Amniotic fluid itself is a poor culture medium for bacteria. 4 However, even small amounts of meconium in amniotic fluid can encourage bacterial growth especially for Escherichia coli and Listeria monocytogenes. A fetus that is exposed to MSAF may be at higher risk for infection than one who is not. Infection could also increase fetal sensitivity to hypoxia and could be a contributing factor for fetal distress during labor. Swallowing of infected amniotic fluid followed by premature defecation by the fetus could also be a likely explanation for MSAF. 5, 6 In a retrospective autopsy review, Burgess and Hutchins 7 noted that meconium passage in utero might be associated with acute chorioamnionitis and acute funisitis. Meconium itself can cause an inflammatory response in the placenta and umbilical cord quite distinct from chorioamnionitis and funisitis. 8 Beebe et al. 9 noted chorioamnionitis to be more frequent in infants with low 1-minute Apgar score, infection, and liver disorder. Obstetricians now recognize that acute chorioamnionitis is more often diagnosable as a histopathological entity than a clinical syndrome of maternal fever, leukocytosis, uterine tenderness, foul-smelling amniotic fluid, and/ or fetal tachycardia. The purpose of this study was to evaluate possible association of histologic acute chorioamnionitis and/or OBJECTIVE: To determine the incidence of meconium -stained amniotic fluid ( MSAF ) and neonatal morbidity in near -term and term deliveries with histologic acute chorioamnionitis and / or funisitis compared to those with normal placental histology.
STUDY DESIGN:
In a retrospective case -control design, we compared the incidence of MSAF and neonatal outcome in 45 cases of acute histologic chorioamnionitis and / or funisitis with 89 cases of normal placental histology. We reviewed the obstetric and neonatal records for perinatal complications and neonatal morbidity.
RESULTS:
Mean birthweights ( 3372 ± 473 vs 3287 ± 518 g ) were similar in infants born to mothers with histologic chorioamnionitis and / or funisitis compared to infants born to mothers with normal placental histology. The incidence of MSAF was significantly higher in the group with acute chorioamnionitis / funisitis ( p < 0.05 ). Similarly, the incidence of admissions to newborn intensive care unit, respiratory distress, meconium aspiration syndrome, and presumed sepsis was also significantly higher ( p < 0.05 ) in this group.
CONCLUSION:
The incidence of MSAF and neonatal morbidity is higher in the presence of acute inflammation of placental membranes. The presence of meconium in the amniotic fluid should alert the physician to the potential for infection and increased neonatal morbidity. 
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funisitis with MSAF and morbidity in near-term and term newborn infants.
MATERIALS AND METHODS
The study was done at Women's and Children's Hospital, Los Angeles County-University of Southern California Medical Center, Los Angeles, CA. A retrospective review of placental pathology of nearterm and term infants ( >35 weeks' gestation) delivered in 1998 was conducted. Placental pathology consistent with acute chorioamnionitis was defined as neutrophilic infiltration of the chorionic plate and/or umbilical cord with spread to the amnion as the predominant finding. Placental findings were classified into two groups according to the histopathology:
Group 1 -acute chorioamnionitis and / or funisitis as the predominant histology; Group 2 -normal histology ( placenta without evidence of acute chorioamnionitis and / or funisitis and other lesions ).
Placentas with histology other than the above were excluded from the study. Obstetric and neonatal data for deliveries in groups 1 and 2 were blindly reviewed for the following characteristics: presence or absence of MSAF, presence or absence of fetal distress as evidenced by late decelerations, birthweight, gestational age, Apgar scores at 1 and 5 minutes, admission to the neonatal intensive care unit (NICU), diagnosis of respiratory distress in the NICU, diagnosis of presumed sepsis in the NICU (antibiotic therapy for 7 days based on clinical symptoms or laboratory findings), and meconium aspiration syndrome with positive chest X-ray.
There were 3243 deliveries in our hospital in 1998. Of these, 2,880 were near-term and term deliveries. During the months of May and June of 1998, all placentas were sent to pathology for histological examination. We reviewed 456 placental pathology reports of nearterm and term deliveries in 1998, of which 322 had to be excluded from the study because they had histological findings other than the two study groups. Of the remaining 134 placentas, 45 were found to have acute chorioamnionitis and/or funisitis (group 1), and 89 were found to be normal without evidence of acute chorioamnionitis and/ or funisitis, and other lesions (group 2). These two groups comprised our study population. The pathologist was not aware of the clinical course or neonatal morbidity.
Statistical analyses were done using GB stat version 7.0 program (Dynamic Microsoft Systems, Silver Spring, MD, 2000). Discrete variables were compared by means of coded -squared contingency analysis. Continuous variables were compared by the Student's t test. A p value of less than 0.05 was considered to indicate significance. Except where noted, data are presented as mean±SD.
RESULTS
Clinical characteristics of the neonates from the two groups are shown in Table 1 . Mean birthweight (3372±473 vs 3287±518 g) and number of infants with Apgar score 5 at 1 and 5 minutes were similar between the two groups. Gestational age of infants in group 1 with histologic chorioamnionitis and/or funisitis was significantly higher (39±2 vs 38±2; p=0.009) when compared to infants in group 2. Incidence of fetal distress (42.2% vs 41.5%; p=0.54) was similar between the two groups. Overall incidence of MSAF was 17.9% in our study population. MSAF was present three times more often in infants born to mothers with histologic chorioamnionitis and/or funisitis. The incidence of MSAF (33% vs 10%) was significantly different between the two groups ( p=0.001).
Outcome data for the infants from the two groups are shown in Table 2 . Significantly more infants from group 1 with histologic chorioamnionitis and/or funisitis required admissions to the NICU (55.5% vs 26.9%). Incidence of respiratory distress requiring therapy with supplemental oxygen was seen more often in infants from group 1 (20% vs 7.8%). Similarly, a higher percentage of infants (8.8% vs 1.1%) from group 1 was diagnosed with MAS. However, the overall incidence of MAS in our study population was 3.7%. Furthermore, 18/45 (40%) of infants in group 1 required septic work-up and treatment with antibiotics for presumed sepsis based on clinical and/ 
DISCUSSION
Placental pathology and its implications for newborn morbidity and mortality are being increasingly recognized. 10, 11 Chorioamnionitis has been linked with preterm birth, cerebral palsy, adverse neonatal outcome in terms of sepsis, and longer hospital stays. 12 Most studies have relied upon a clinical diagnosis of chorioamnionitis as the maternal parameter for neonatal outcome. Previous data suggest that there is no single clinical correlate to diagnose or exclude chorioamnionitis in the mother with a useful degree of accuracy. 13 The recognition of chorioamnionitis as a histopathologic entity and appreciation of its pathogenesis have introduced new dimensions for investigation of the role of proinflammatory cytokines in the pathogenesis of perinatal mortality and morbidity. 8 Histological chorioamnionitis has been reported in about 10% of full-term deliveries.
14 In this study, we found histological chorioamnionitis in 9.86% of deliveries -a number that is consistent with previous reports.
The incidence of MSAF in our study was 17.9%. This is also comparable to other published data. 15 As shown in Table 1 , the two groups of neonates are comparable in terms of birthweight, Apgar scores, and incidence of fetal distress. The percentage of babies with MSAF, however, was significantly different between the two groups, indicating that some underlying pathology other than fetal distress caused the fetus to pass meconium in utero. The most important finding on placental histological examination was acute chorioamnionitis and/or funisitis. We excluded all other pathological findings such as infarcts, hemorrhage, and abruptio by selecting out only placentas with predominant acute inflammatory findings into group 1. By doing this, we hoped to exclude major causes of fetal distress that would lead to meconium passage by the fetus. Therefore, on the basis of histopathology, it would appear that acute chorioamnionitis and/or funisitis was an important factor in the etiology of MSAF.
The two groups of infants differed in terms of neonatal course. A higher percentage of babies in group 1 was admitted to the NICU for monitoring. As shown in Table 2 , neonates in group 1 were found to have respiratory distress more frequently than in group 2. Meconium aspiration syndrome with positive chest X-ray findings was also more frequent in group 1. A higher percentage of babies was presumed to be septic in group 1 and was treated with antibiotics for 7 days or more. This could possibly mean that infected babies are more likely to aspirate meconium and be symptomatic from the same.
Upon reviewing the placental pathology of the 24 babies with MSAF, 62.5% was found to have acute chorioamnionitis and/or funisitis. Of the 110 babies with clear amniotic fluid, 27.2% was found to have acute chorioamnionitis and/or funisitis. Although this would seem that MSAF is associated with acute chorioamnionitis and/or funisitis, larger studies are required to prove the same.
Bobitt and Ledger
16 emphasized the potential diagnostic value of amniotic fluid analysis in recognizing early intrauterine infection. Wen et al. 6 reported significantly higher rate of intra-amniotic infection in women with MSAF. Piper et al. 15 stated that MSAF is associated with an increased peripartum infection independent of other risk factors. Romero et al. 5 recognized MSAF as a significant risk factor for microbial invasion of the amniotic cavity and preterm delivery. Amniotic fluid has physiologic antimicrobial properties that are impaired by meconium. Florman and Teubner 17 demonstrated that meconium enhances bacterial growth of E. coli and L. monocytogenes in amniotic fluid in in vitro experiments. Schlievert et al. 18 noted that bacterial growth inhibition by amniotic fluid could possibly be due to altered zinc and/or phosphate content. Swallowed bacteria may induce meconium passage by the fetus by causing enteritis due to release of endotoxins that increase gut motility. Blot et al. 19 in 1983 showed an association between fetal tachycardia and MSAF as probable sign of fetal infection. Salafia et al. 20 showed that abnormal fetal heart rate patterns were more likely to be present in cases with histologic chorioamnionitis. Altshuler 8 also noted that chorioamnionitis results from infection by one or more pathogens and that the presence of meconium exacerbates chorioamnionitis, whereas meconium itself does not cause chorioamnionitis. Hyde et al. 21 proposed that in chorioamnionitis and funisitis, bacterial products cause placental and umbilical cord vasoconstriction, leading to fetal hypoperfusion and fetal hypoxia. Thus, infection can lead to meconium passage by the fetus by several mechanisms. Miller et al. 3 in 1975 stated that MSAF in the absence of fetal asphyxia is not a sign of fetal distress and that a combination of MSAF and fetal asphyxia (as defined by late deceleration and acidosis) enhances the potential for meconium aspiration and poor neonatal outcome. Other investigators have evaluated meconium passage as a timerelated event with late meconium passage posing no untoward fetal or neonatal consequences. 3, 19, 22 Thus, meconium and chorioamnionitis have both been issues of great clinical significance and controversy for several decades.
Chorioamnionitis, whether histologic or clinical, has traditionally been linked to preterm births. Grether and Nelson 23 in 1997 stated that exposure to intrauterine infection was associated with a marked increase in the risk of cerebral palsy in infants of normal birthweight. Neurodevelopmental concerns in full-term infants in relation to placental pathology are being increasingly recognized. 10 Altshuler 8 urges perinatologists to include placental pathology in all investigations of chorioamnionitis. Many cases of chorioamnionitis occur in normal healthy neonates. 24, 25 Similarly, MSAF is seen in a significant number of healthy newborns; however, these may co-exist and lead to serious complications. There are several limitations to our study such as small sample size, lack of fetal acid-base status, and retrospective nature. Larger prospective studies involving placental pathology are required to confirm our observations. Based on our study findings, we conclude that histological acute chorioamnionitis and funisitis are associated with a higher incidence of MSAF independent of fetal distress as a risk factor. This does not imply that every baby born with MSAF is infected, but alerts the physician to the potential for infection and increased morbidity in that infant. This is particularly important in this era of early discharge of newborns from the hospital. It also emphasizes the importance of placental pathology as a diagnostic aid in the management of perinatal complications.
